Atg9a Activators refer to a class of chemical compounds specifically identified for their role in upregulating or promoting the expression of Atg9a, a gene encoding the Autophagy-related protein 9A in humans. This protein is pivotal in the process of autophagy, a cellular mechanism for degrading and recycling cellular components. Atg9a plays a crucial role not only in autophagy but also in other membrane remodeling processes, such as plasma membrane repair, and functions as a lipid scramblase. The chemical compounds categorized as Atg9a Activators exhibit a unique ability to interact with cellular mechanisms, leading to an increase in the expression of the Atg9a protein. Their mode of action can vary widely, encompassing different biochemical pathways and molecular interactions. Some of these compounds may act by inhibiting negative regulators of autophagy, thereby indirectly promoting the expression of Atg9a. Others might directly interact with the regulatory elements of the Atg9a gene, enhancing its transcription.
The discovery and characterization of Atg9a Activators have opened up new avenues in the study of cellular autophagy processes. These compounds are found to influence various aspects of autophagy, ranging from the initiation of autophagosome formation to the later stages of autophagic flux. For instance, some Atg9a Activators might function by mimicking cellular stress conditions, such as hypoxia, thereby triggering the hypoxia response elements in the Atg9a gene promoter, leading to increased protein expression. Others could operate by modulating key signaling pathways like mTOR (mechanistic target of rapamycin) or AMPK (AMP-activated protein kinase), which are well-known to play significant roles in autophagy regulation. Additionally, certain Atg9a Activators might exert their effects by altering the cellular metabolic state, thus indirectly influencing the autophagic machinery. The diverse mechanisms of action of these compounds reflect the complexity and multifaceted nature of autophagy as a cellular process. Understanding the specific interactions and effects of Atg9a Activators at the molecular level is crucial for a comprehensive understanding of their role in the regulation of autophagy.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin might upregulate ATG9A by inhibiting mTOR, a negative regulator of autophagy, thus promoting autophagic processes where ATG9A is essential. | ||||||
Cobalt(II) chloride | 7646-79-9 | sc-252623 sc-252623A | 5 g 100 g | $64.00 $176.00 | 7 | |
Mimicking hypoxic conditions, Cobalt(II) chloride could induce ATG9A expression by activating hypoxia response elements in its gene promoter, as hypoxia is known to increase ATG9A levels. | ||||||
Spermidine | 124-20-9 | sc-215900 sc-215900B sc-215900A | 1 g 25 g 5 g | $57.00 $607.00 $176.00 | ||
Spermidine, known to induce autophagy, might increase ATG9A expression due to its role in autophagosome formation and recycling of cellular components. | ||||||
D-(+)-Trehalose Anhydrous | 99-20-7 | sc-294151 sc-294151A sc-294151B | 1 g 25 g 100 g | $30.00 $167.00 $260.00 | 2 | |
Trehalose could potentially upregulate ATG9A by enhancing autophagy as a protective mechanism against cellular stress, where ATG9A is crucial for autophagosome formation. | ||||||
Metformin-d6, Hydrochloride | 1185166-01-1 | sc-218701 sc-218701A sc-218701B | 1 mg 5 mg 10 mg | $292.00 $822.00 $1540.00 | 1 | |
Metformin, by activating AMPK, might increase ATG9A expression, as AMPK activation is linked to the promotion of autophagic processes involving ATG9A. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol might upregulate ATG9A expression as part of the cellular response to oxidative stress, which often involves autophagic processes that require ATG9A. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin could induce ATG9A expression by influencing autophagic pathways, particularly in response to its anti-inflammatory and antioxidant effects. | ||||||
Nicotinamide | 98-92-0 | sc-208096 sc-208096A sc-208096B sc-208096C | 100 g 250 g 1 kg 5 kg | $44.00 $66.00 $204.00 $831.00 | 6 | |
Nicotinamide might upregulate ATG9A expression by affecting NAD+ levels and cellular metabolism, thereby influencing autophagic processes where ATG9A is involved. | ||||||